Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

cGAS-STING signaling in cancer immunity and immunotherapy
Huashan Du, Tianmin Xu, Manhua Cui
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110972-110972
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Intracellular Self‐Assembly Driven Nucleus‐Targeted Photo‐Immune Stimulator with Chromatin Decompaction Function for Robust Innate and Adaptive Antitumor Immunity
Xiu Zhao, Kaixiang Zhang, Yiyang Wang, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 17
Closed Access | Times Cited: 71
NSUN2 is a glucose sensor suppressing cGAS/STING to maintain tumorigenesis and immunotherapy resistance
Tingjin Chen, Zhigang Xu, Luo Jie, et al.
Cell Metabolism (2023) Vol. 35, Iss. 10, pp. 1782-1798.e8
Closed Access | Times Cited: 58
Mn-based cGAS-STING activation for tumor therapy
Aiping Huang, Wenhu Zhou
Chinese Journal of Cancer Research (2023) Vol. 35, Iss. 1, pp. 19-43
Open Access | Times Cited: 43
cGAS–STING, an important signaling pathway in diseases and their therapy
Qijie Li, Ping Wu, Qiujing Du, et al.
MedComm (2024) Vol. 5, Iss. 4
Open Access | Times Cited: 18
Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors
Maria Lucia Iacovino, Chiara Carmen Miceli, Marco De Felice, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1133-1133
Open Access | Times Cited: 37
The role of p53 in anti-tumor immunity and response to immunotherapy
Lindsey Carlsen, Shengliang Zhang, Xiaobing Tian, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 30
Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: A comprehensive review of strategies and future perspectives
Cuiqing Huang, Ni Shao, Yanyu Huang, et al.
Materials Today Bio (2023) Vol. 23, pp. 100839-100839
Open Access | Times Cited: 30
Nanoparticle‐Mediated STING Activation for Cancer Immunotherapy
Yongjuan Li, Xinyan Li, Jinmeng Yi, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 19
Closed Access | Times Cited: 26
IUPHAR ECR review: The cGAS-STING pathway: Novel functions beyond innate immune and emerging therapeutic opportunities
Xu He, Abdalla M. Wedn, Jian Wang, et al.
Pharmacological Research (2024) Vol. 201, pp. 107063-107063
Open Access | Times Cited: 11
Anti-tumor role and molecular mechanism of vanillic acid
Xingan Hao, Zhixiao Gao, Mingzhe Hu
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Bidirectional regulation of the cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon gene pathway and its impact on hepatocellular carcinoma
Aifang Nie, Zimo Xiao, Jiali Deng, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 2
Closed Access
Ginsenoside RG3 Synergizes With STING Agonist to Reverse Cisplatin Resistance in Gastric Cancer
Zhongqi Lu, Yihang Fu, Qiang Fu, et al.
Food Science & Nutrition (2025) Vol. 13, Iss. 1
Open Access
Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers
Vito Amodio, Gianluca Mauri, Nicole M. Reilly, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2638-2638
Open Access | Times Cited: 47
STING activation in macrophages by vanillic acid exhibits antineoplastic potential
Man Zhu, Xiaoyu Tang, Zeren Zhu, et al.
Biochemical Pharmacology (2023) Vol. 213, pp. 115618-115618
Closed Access | Times Cited: 18
Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcoma
Dongquan Xiang, Xin-Li Han, Jianxiong Li, et al.
Materials Today Bio (2023) Vol. 20, pp. 100675-100675
Open Access | Times Cited: 18
The complexity of immune evasion mechanisms throughout the metastatic cascade
Nicole M. Haynes, Thomas B Chadwick, Belinda S. Parker
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1793-1808
Closed Access | Times Cited: 5
Targeting LYPLAL1-mediated cGAS depalmitoylation enhances the response to anti-tumor immunotherapy
Yizeng Fan, Yang Gao, Li Nie, et al.
Molecular Cell (2023) Vol. 83, Iss. 19, pp. 3520-3532.e7
Open Access | Times Cited: 14
DNA Repair Deficiency Regulates Immunity Response in Cancers: Molecular Mechanism and Approaches for Combining Immunotherapy
Yi Xu, Somaira Nowsheen, Min Deng
Cancers (2023) Vol. 15, Iss. 5, pp. 1619-1619
Open Access | Times Cited: 13
Nanoparticle targeting cGAS-STING signaling in disease therapy
Zhou Lan, Yu Huang, Yuzhang Wu, et al.
Nano Research (2024) Vol. 17, Iss. 8, pp. 7315-7336
Closed Access | Times Cited: 3
Nanoparticle‐Mediated STING Agonist Delivery for Enhanced Cancer Immunotherapy
Qinghao Zhou, Yu Zhou, Taiyuan Li, et al.
Macromolecular Bioscience (2021) Vol. 21, Iss. 8
Closed Access | Times Cited: 27
Crosstalk between cGAS-STING pathway and autophagy in cancer immunity
Qijun Lu, Yukun Chen, Jianwen Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Targeting the loss of cGAS/STING signaling in cancer
Nobunari Sasaki, Mizuki Homme, Shunsuke Kitajima
Cancer Science (2023) Vol. 114, Iss. 10, pp. 3806-3815
Open Access | Times Cited: 10
In situ injectable hydrogel encapsulating Mn/NO-based immune nano-activator for prevention of postoperative tumor recurrence
Shengnan Huang, Chenyang Zhou, Chengzhi Song, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 2, pp. 100901-100901
Open Access | Times Cited: 3
cGAS-STING Signaling Pathway and Liver Disease: From Basic Research to Clinical Practice
Bangjie Chen, Xianyue Rao, Xinyi Wang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 22
Stimulatory and inhibitory activity of STING ligands on tumor-reactive human gamma/delta T cells
Ruben Serrano, Marcus Lettau, Michał Zarobkiewicz, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top